NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Immuno Nano Med

Immuno Nano Med

Private
Ames, IowaHealthcare & Life Scienceshttps://immunonanomed.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$360,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Immuno Nano Med is a biotechnology company developing room-temperature-stable, dry powder influenza vaccines designed to provide broad, needle-free immunity and eliminate global cold chain dependencies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

needle-free vaccineinhalable vaccineinfluenza vaccinevaccine platformdry powder vaccinethermostable vaccineparticle-based vaccineroom-temperature stablenanoparticle vaccinevaccine deliverynasal vaccinecold-chain freeinfectious diseasepolyanhydride particleself-administrationanimal healthvaccine licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immuno Nano Med Comparables

Compare Immuno Nano Med with similar companies based on industry and business-model similarity.

Immuno Nano Med comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivaldi Biosciences, Inc.
77%
Altimmune Inc
74%
Tff Pharmaceuticals Inc
71%

Immuno Nano Med Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
GrantOct 1, 2025
GrantAug 22, 2025
AcceleratorAug 22, 2025

Immuno Nano Med Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 19, 2025

    $15K raised from University of Iowa John Pappajohn Entrepreneurial Center.

  • Oct 1, 2025

    $305K grant awarded by the National Science Foundation.

Immuno Nano Med Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Immuno Nano Med Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Immuno Nano Med's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmes, Iowa
Employee Range2
Year Founded2020
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.